Human Insulin Market Trends, Development and Demand Forecast to 2020


The global human insulin market is expected to witness double digit growth during the period 2015 to 2020 to reach $48,487.7 million value by 2020.

The global human insulin market is being driven by increasing prevalence of diabetic population, and rise in aging population. Diabetes is a chronic and non-communicable disease, and its global prevalence is increasing enormously. Rising prevalence of obesity, rising awareness about diabetic care, and technological advancement in insulin delivery devices are some of the factors driving the growth of the global human insulin market. Growing demand of biosimilar drugs, due to its cost effectiveness, pose an opportunity for the growth of the human insulin market. In addition, increasing usage of insulin pens for the administration of insulin helps to inject the accurate dose of insulin at a time. However, high insulin analog cost and strict regulatory requirements for approval of human insulin are inhibiting the growth of the global human insulin market. Request for Report Sample: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Report%20sample Increasing prevalence of diabetes, increasing number of geriatric population, rising prevalence of obesity and increasing R&D investment for more effective insulin are driving the growth of the human insulin market in North America. The North American human insulin market is expected to grow by a CAGR of 11.8% during the period 2015 to 2020. In Europe, according to International Diabetic Federation in 2013, approximately 52 million people were suffering from diabetes in Europe. The European human insulin market is expected to grow by a CAGR of 12.6% during the period 2015 to 2020. Thus, increasing prevalence of diabetes would increase the usage of human insulin. Also, in Asia Pacific region, several government initiatives are implemented to create awareness about prevention and treatment of diabetes. The government is also taking initiatives to improve healthcare infrastructure and provide treatment in rural areas. In Asia-Pacific, the human insulin market is expected to witness CAGR of 13.9% during the period 2015 to 2020. Enquiry Before Buying: https://www.psmarketresearch.com/enquiry-form.php?enqid=176&title=Enquiry%20before%20purchase The global human insulin market has a fragmented structure with large number of companies operating in the market. The key players in the human insulin market include Sanofi, Novo Nordisk A/S, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer, Inc., Merck & Co., and Julphar. About P&S Market Research P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research based consulting services across a range of industries. With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions. Contact: Deep Assistant – Client Partner 347, 5th Ave. #1402 New York City, NY -10016 Toll-free: +1-888-778-7886 (USA/Canada) Email: enquiry@psmarketresearch.com Web: https://www.psmarketresearch.com

Products or Services

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe.

Contact Information

P&S Market Research

347 5th Ave. #1402- 210
New York City
10016
United States
Phone : 8887787886
View website

Published in

Business

Published on

Aug 25, 2016

Social Links

PRnob Facebook Page Twitter page of PRnob.com Google+ of Prnob.com LinkedIn page of PRnob.com